Description
The NxTAG® Respiratory Pathogen Panel + SARS‑CoV‑2 (NxTAG RPP + SARS‑CoV‑2), developed for use on the NxTAG-Enabled MAGPIX® System, is a qualitative test for the detection of nucleic acids from multiple respiratory viruses and bacteria in nasopharyngeal swabs in UTM, Liquid Amies (ESwab™), or equivalent.
The NxTAG RPP + SARS‑CoV‑2 Assay offers:
Comprehensive Testing: Detects 23 pathogens, including SARS‑CoV‑2 (ORF1ab and M gene), in a single tube, enabling the accurate diagnosis and treatment of respiratory illnesses with overlapping symptoms.
Scalable Throughput: Process up to 96 samples in less than 3 hours post-extraction, accommodating variable, day-to-day testing demand.
Minimal Hands-On Time: Pre-plated, lyophilized reagents facilitate a simple workflow with just one pipetting step, ensuring an easy fit in any lab’s daily routine.
Viral Targets:
Adenovirus
Coronavirus 229E
Coronavirus HKU1
Coronavirus NL63
Coronavirus OC43
Human Bocavirus
Human Metapneumovirus
Influenza A
Influenza A – subtype H1
Influenza A – subtype H3
Influenza A 2009 H1N1
Influenza B
Parainfluenza 1
Parainfluenza 2
Parainfluenza 3
Parainfluenza 4
Respiratory Syncytial Virus A
Respiratory Syncytial Virus B
Rhinovirus/Enterovirus
SARS‑CoV‑2
Bacterial Targets:
Chlamydophila pneumoniae
Legionella pneumophila
Mycoplasma pneumoniae
